Incidence Rate and Predictors of Intracranial Hemorrhage in Patients With Atrial Fibrillation: A Report From the Nationwide COOL‐AF Registry
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Rungroj Krittayaphong, Kasem Ratanasumawong, Komsing Methavigul, Chaiyasith Wongvipaporn, Gregory Y. H. Lip |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
How to Apply Predictive Model in Real‐World Practice: The Standard of Model Validation
by: Rungroj Krittayaphong
Published: (2025)
by: Rungroj Krittayaphong
Published: (2025)
The Applicability of Novel Predictor of Intracranial Hemorrhage in Patients With Atrial Fibrillation in the Contemporary Real‐World Clinical Practice
by: Naoya Kataoka, et al.
Published: (2025)
by: Naoya Kataoka, et al.
Published: (2025)
The Neutrophil‐to‐Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP‐II) Cohort Study
by: Eva Soler‐Espejo, et al.
Published: (2025)
by: Eva Soler‐Espejo, et al.
Published: (2025)
Incremental Value of NT‐proBNP Over HCM‐AF Score in Risk Stratification for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
by: Yi‐Peng Gao, et al.
Published: (2026)
by: Yi‐Peng Gao, et al.
Published: (2026)
Association Between Changes in Heart Rate and Adverse Events in Patients With Non‐Valvular Atrial Fibrillation: A Post Hoc Analysis of the J‐RHYTHM Registry
by: Eitaro Kodani, et al.
Published: (2025)
by: Eitaro Kodani, et al.
Published: (2025)
How to Reduce the Incidence of Recurrence Following Catheter Ablation for Atrial Fibrillation
by: Naoya Kataoka, et al.
Published: (2026)
by: Naoya Kataoka, et al.
Published: (2026)
Evaluation of the Presence of Native Valvular Disease in Patients With Atrial Fibrillation Using the EHRA (Evaluated Heartvalves, Rheumatic, or Artificial) Classification
by: Antonio Escolar Conesa, et al.
Published: (2025)
by: Antonio Escolar Conesa, et al.
Published: (2025)
A Valuable Contribution to Atrial Fibrillation Ablation in Young Adults: The Role of Long‐Term Follow‐Up and Silent Atrial Fibrillation Monitoring
by: Elif Y. Arı, et al.
Published: (2025)
by: Elif Y. Arı, et al.
Published: (2025)
Questioning the Rhythm: A Closer Look at Heart Rate Trends in Atrial Fibrillation
by: Ibrahim Nagmeldin Hassan
Published: (2025)
by: Ibrahim Nagmeldin Hassan
Published: (2025)
Clinical Characteristics and Outcomes of Catheter Ablation in Young Patients With Atrial Fibrillation
by: Xuewen Wang, et al.
Published: (2025)
by: Xuewen Wang, et al.
Published: (2025)
How to Assess the Functional Impact of Atrial Fibrillation in Patients With Heart Failure
by: Naoya Kataoka, et al.
Published: (2025)
by: Naoya Kataoka, et al.
Published: (2025)
Impact of Atrial Fibrillation at the Time of Coronary Revascularization on Long‐Term Outcomes: From the G‐NUH Registry
by: Jaemyoung Lee, et al.
Published: (2025)
by: Jaemyoung Lee, et al.
Published: (2025)
Tumor Necrosis Factor Superfamily 14: A Potential Predictor of Atrial Fibrillation Recurrence After Catheter Ablation
by: Dongtao Zhou, et al.
Published: (2026)
by: Dongtao Zhou, et al.
Published: (2026)
Application Value and Safety Analysis of Warfarin, Rivaroxaban, and Dabigatran Ester in Elderly Patients With Atrial Fibrillation
by: Cheng Chen, et al.
Published: (2024)
by: Cheng Chen, et al.
Published: (2024)
Corrigendum to “Edoxaban Monotherapy in Nonvalvular Atrial Fibrillation Patients with Coronary Artery Disease”
Published: (2025)
Published: (2025)
How to Demonstrate the Association Between the Inflammation and Atrial Fibrillation Recurrence
by: Naoya Kataoka, et al.
Published: (2025)
by: Naoya Kataoka, et al.
Published: (2025)
Assessment of Risk Factors for Atrial Fibrillation With a Particular Focus on Echocardiographic Parameters, in Patients With Acute Myocardial Infarction
by: Beata Jacuś, et al.
Published: (2025)
by: Beata Jacuś, et al.
Published: (2025)
A Predictive Nomogram of In‐Hospital Mortality After 48 h for Atrial Fibrillation Patients in the Coronary Care Unit
by: Wenhui Wang, et al.
Published: (2024)
by: Wenhui Wang, et al.
Published: (2024)
Serum Urate and Atrial Fibrillation: A Bidirectional Mendelian Randomization Study
by: Shandong Yu, et al.
Published: (2025)
by: Shandong Yu, et al.
Published: (2025)
The Relationship Between Ambulatory Arterial Stiffness Index and Incident Atrial Fibrillation
by: Christopher Boos
Published: (2024)
by: Christopher Boos
Published: (2024)
Association Between Hemoglobin Glycation Index and Mortality in Critically Ill Patients With Atrial Fibrillation: A Retrospective Cohort Study
by: Xianglin Long, et al.
Published: (2026)
by: Xianglin Long, et al.
Published: (2026)
The Effect of Age on 1‐Year Readmissions in Atrial Fibrillation Patients: Trends and Insights From a Conflict‐Stricken Country
by: Ibrahim Antoun, et al.
Published: (2025)
by: Ibrahim Antoun, et al.
Published: (2025)
Enhancing Quality of Life in Symptomatic Paroxysmal Atrial Fibrillation Patients: A Systematic Analysis of Cognitive Behavioral Therapy Interventions
by: Pratik Agarwal, et al.
Published: (2024)
by: Pratik Agarwal, et al.
Published: (2024)
Atrial Fibrillation Recurrence Risk After Catheter Ablation in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis
by: Pongprueth Rujirachun, et al.
Published: (2025)
by: Pongprueth Rujirachun, et al.
Published: (2025)
Relationship between Brain Natriuretic Peptide and Thromboembolic Events in Elderly Patients with Nonvalvular Atrial Fibrillation
by: Hongxia Wang, et al.
Published: (2024)
by: Hongxia Wang, et al.
Published: (2024)
Critique on “Evaluation of the Presence of Native Valvular Disease in Patients With Atrial Fibrillation Using the EHRA (Evaluated Heartvalves, Rheumatic, or Artificial) Classification”
by: Arooha Javed, et al.
Published: (2025)
by: Arooha Javed, et al.
Published: (2025)
Comment on “The Relationship Between Ambulatory Arterial Stiffness Index and Incident Atrial Fibrillation”
by: Mustafa Candemir, et al.
Published: (2024)
by: Mustafa Candemir, et al.
Published: (2024)
Effect of Postoperative Atrial Fibrillation After Cardiac Surgery: A Meta‐Analysis
by: Fangzhou Qu, et al.
Published: (2024)
by: Fangzhou Qu, et al.
Published: (2024)
Pulmonary Vein Isolation Suppresses Atrial Remodeling and Enhances Quality of Life in HFpEF Patients With Atrial Fibrillation: A Randomized Controlled Trial
by: Qun Tang, et al.
Published: (2026)
by: Qun Tang, et al.
Published: (2026)
Atrial Fibrillation Ablation Using Cryoballoon Versus Robotic Magnetic Navigation in Patients With Pulmonary Vein Variant
by: Xiao-Yu Liu, et al.
Published: (2026)
by: Xiao-Yu Liu, et al.
Published: (2026)
Meta‐Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease
by: Mushood Ahmed, et al.
Published: (2024)
by: Mushood Ahmed, et al.
Published: (2024)
Letter Regarding “Outcomes of Bolus Dose Furosemide Versus Continuous Infusion in Patients With Acute Decompensated Left Ventricular Failure and Atrial Fibrillation”
by: Ahmed M. Gazer, et al.
Published: (2024)
by: Ahmed M. Gazer, et al.
Published: (2024)
Generalizability of Low‐Voltage Zone‐Based Risk Scores After Atrial Fibrillation Ablation
by: Laiba Anwar, et al.
Published: (2026)
by: Laiba Anwar, et al.
Published: (2026)
How to Integrate Echocardiographic Risk Factors for Atrial Fibrillation Following Acute Myocardial Infarction
by: Naoya Kataoka, et al.
Published: (2025)
by: Naoya Kataoka, et al.
Published: (2025)
RETRACTION: Vigorous Physical Activity and Atrial Fibrillation in Healthy Individuals: What Is the Correct Approach?
Published: (2025)
Published: (2025)
Management of Antithrombotic Therapy in Patients With Coexisting Atrial Fibrillation and Coronary Artery Disease Who Underwent Percutaneous Coronary Intervention Within the Last Year
by: Sebastian König, et al.
Published: (2025)
by: Sebastian König, et al.
Published: (2025)
Atrial Fibrillation and Obstructive Sleep Apnea: Do Mortality Trends Reflect Disease Burden or Diagnostic Gaps?
by: Naoya Kataoka, et al.
Published: (2025)
by: Naoya Kataoka, et al.
Published: (2025)
Health Care Resource Utilization With Dronedarone Versus Sotalol Following Catheter Ablation in Adults With Atrial Fibrillation
by: Emily P. Zeitler, et al.
Published: (2025)
by: Emily P. Zeitler, et al.
Published: (2025)
Correction to “Physician and Patient Preferences for Oral Anticoagulation Therapy Decision Making in Atrial Fibrillation: Results From a National Best–Worst Scaling Survey in Türkiye”
Published: (2025)
Published: (2025)
C‐Reactive Protein–Albumin–Lymphocyte (CALLY) Index as an Independent Risk Factor for Postoperative Atrial Fibrillation Recurrence
by: Ye Deng, et al.
Published: (2025)
by: Ye Deng, et al.
Published: (2025)
Similar Items
-
How to Apply Predictive Model in Real‐World Practice: The Standard of Model Validation
by: Rungroj Krittayaphong
Published: (2025) -
The Applicability of Novel Predictor of Intracranial Hemorrhage in Patients With Atrial Fibrillation in the Contemporary Real‐World Clinical Practice
by: Naoya Kataoka, et al.
Published: (2025) -
The Neutrophil‐to‐Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP‐II) Cohort Study
by: Eva Soler‐Espejo, et al.
Published: (2025) -
Incremental Value of NT‐proBNP Over HCM‐AF Score in Risk Stratification for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
by: Yi‐Peng Gao, et al.
Published: (2026) -
Association Between Changes in Heart Rate and Adverse Events in Patients With Non‐Valvular Atrial Fibrillation: A Post Hoc Analysis of the J‐RHYTHM Registry
by: Eitaro Kodani, et al.
Published: (2025)